Taro 2003 News Archive

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

2003

Date	Title
12/10/2003	Taro's ElixSure^TM Medicines Receive the Good Houskeeping Institute's
12/9/2003	Taro Receives ANDA Approvals for Augmented Betamethasone Dipropionate Cream and Gel
12/1/2003	Taro Completes $50 Million Non-convertible Debt Offering
11/17/2003	Taro Announces Filing of ANDA for Gabapentin Capsules, 100 mg, 300 mg, 400mg
11/14/2003	Taro Added to NASDAQ Biotechnology Index
11/12/2003	Taro Receives Tentative Approval for Fluconazole Tablets ANDA
10/30/2003	Taro to Report 3rd Quarter 2003 Taro Reports Record Third Quarter and Nine Month 2003 Resultsand Conduct Conference Call on October 30, 2003
10/21/2003	Taro to Report 3rd Quarter 2003 Results and Conduct Conference Call on October 30, 2003
7/24/2003	Taro Reports Record 2nd Quarter and Six-Month 2003 Results Call on July 24, 2003
7/10/2003	Taro to Report 2nd quarter 2003 Results and Conduct Conference Call on July 24, 2003
6/23/2003	Taro to Launch ElixSure^TM OTC Medication
6/2/2003	Taro Completes $60 Million Non-Convertible Debt Offering
5/22/2003	Taro Announces $60 Million Non-Convertible Debt Offering
4/16/2003	Taro Reports 1St Quarter 2003 Results
4/11/2003	Taro to Report 1st Quarter 2003 Results and Conduct Conference Call on April 16, 2003
4/10/2003	Taro Receives Approval for Ammonium Lactate Cream, 12% ANDA
3/31/2003	Taro Announces "AA" Bond Rating in Israel
3/13/2003	Taro Receives Approval for Etodolac extended Release Tablets ANDA
2/20/2003	Taro Pharmaceuticals Reports Record 2002 Results
2/18/2003	Taro Acquires Pharmaceutical Manufacturing and Research Center in Ireland
2/3/2003	Taro to Present at Merrill Lynch Healthcare Conference
1/16/2003	Taro Establishes TaroPharma Division for Sales of Proprietary Prescription Products in the U.S.
01/15/2003	Taro to License Four Branded Pharmaceutical Products Lines From Medicis